Parallax Volatility Advisers’s Translational Development Acquisition Corp Units TDACU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-50,400
Closed -$511K 1888
2025
Q1
$511K Hold
50,400
﹤0.01% 1186
2024
Q4
$505K Buy
+50,400
New +$505K ﹤0.01% 1500

Other funds holding TDACU

Parallax Volatility Advisers's TDACU Position: Q2 2025 in Review

Parallax Volatility Advisers sold out of Translational Development Acquisition Corp Units (TDACU) in Q2 2025, closing a stake of 50,400 shares — an estimated $511K sold.

Parallax Volatility Advisers first reported a position in TDACU in Q4 2024 and held it in 2 quarters. The position peaked at $511K in Q1 2025. 9 funds tracked by Wall St. Rank hold TDACU as of Q2 2025.

  • Parallax Volatility Advisers reported no remaining Translational Development Acquisition Corp Units position as of Q2 2025 after selling out during the quarter.
  • Parallax Volatility Advisers sold 50,400 Translational Development Acquisition Corp Units shares in Q2 2025, an estimated $511K.
  • Parallax Volatility Advisers first reported a position in Translational Development Acquisition Corp Units in Q4 2024 and held it in 2 quarters.
  • Parallax Volatility Advisers's Translational Development Acquisition Corp Units position peaked at $511K in Q1 2025.
  • 9 funds tracked by Wall St. Rank held Translational Development Acquisition Corp Units as of Q2 2025.

Based on Parallax Volatility Advisers's 13F filing for Q2 2025, filed 14 Aug 2025.